Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
100%(2 trials)

Phase Distribution

Ph phase_2
1
33%
Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (50.0%)
N/A1 (50.0%)

Trials by Status

completed267%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
recruiting

Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat

NCT06569589
completedphase_2

Effect of KNO3 Compared to KCl on Oxygen UpTake in Heart Failure With Preserved Ejection Fraction (KNO3CK OUT HFPEF)

NCT02840799
completednot_applicable

Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate

NCT02665117

Clinical Trials (3)

Showing 3 of 3 trials
NCT06569589

Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat

Recruiting
NCT02840799Phase 2

Effect of KNO3 Compared to KCl on Oxygen UpTake in Heart Failure With Preserved Ejection Fraction (KNO3CK OUT HFPEF)

Completed
NCT02665117Not Applicable

Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3